Sahin M, Gursoy A, Tutuncu N B, Guvener D N
Department of Endocrinology and Metabolism, Baskent University, Ankara, Turkey.
Clin Endocrinol (Oxf). 2006 Oct;65(4):514-8. doi: 10.1111/j.1365-2265.2006.02625.x.
Controversy surrounds the evaluation of nodules with indeterminate cytology results. Malignancy rates in these nodules are not low. We examined the malignancy rates in nodules that showed follicular neoplasm or atypical cells on cytology and attempted to predict malignancy based on ultrasonographic features.
We retrospectively analysed 5 years' cytopathology results of fine-needle aspiration biopsy (FNAB) specimens of indeterminate follicular thyroid lesions prior to thyroidectomy. The prevalence of malignancy on final histology was determined. The sonographic features of the thyroid nodules with respect to size, echogenicity, echo structure, border shape and presence of calcification were analysed.
A total of 86 patients (15 men, 61 women; mean age 52.1 +/- 12.5 years) with indeterminate cytology underwent thyroidectomy and had histopathological diagnoses. The average nodule was 18.9 +/- 12.3 mm. The prevalence of malignancy in patients with atypical cell cytology was 51.7% (30 of 59), and the prevalence of malignancy in patients with follicular neoplasm cytology was 15% (4 of 27). Malignancy prevalence was higher in patients who had follicular neoplasm cytology with atypical cells than in those without atypical cells (2 of 7 and 2 of 20, respectively). We found no significant correlations between sonographic or clinical features and malignancy in this patient group. Sonographic features and nodule size are not useful predictors of malignancy.
Until better molecular markers for malignancy are developed, surgical consultation remains necessary after examination of cytologically indeterminate FNAB specimens in patients with follicular thyroid lesions. But in follicular lesions without atypical cells the malignancy rate is low and reassessment later on could be an alternative approach.
对于细胞学检查结果不确定的结节的评估存在争议。这些结节的恶性率并不低。我们研究了细胞学检查显示为滤泡性肿瘤或非典型细胞的结节的恶性率,并尝试根据超声特征预测恶性情况。
我们回顾性分析了甲状腺切除术前对滤泡性甲状腺病变进行细针穿刺活检(FNAB)标本的5年细胞病理学结果。确定最终组织学检查中恶性肿瘤的患病率。分析甲状腺结节在大小、回声性、回声结构、边界形状和钙化情况方面的超声特征。
共有86例细胞学检查结果不确定的患者(15例男性,61例女性;平均年龄52.1±12.5岁)接受了甲状腺切除术并获得组织病理学诊断。平均结节大小为18.9±12.3毫米。非典型细胞细胞学检查患者的恶性患病率为51.7%(59例中的30例),滤泡性肿瘤细胞学检查患者的恶性患病率为15%(27例中的4例)。有非典型细胞的滤泡性肿瘤细胞学检查患者的恶性患病率高于无非典型细胞的患者(分别为7例中的2例和20例中的2例)。在该患者组中,我们未发现超声或临床特征与恶性情况之间存在显著相关性。超声特征和结节大小并非恶性情况的有用预测指标。
在开发出更好的恶性肿瘤分子标志物之前,对于滤泡性甲状腺病变患者,在检查细胞学检查结果不确定的FNAB标本后,仍有必要进行手术咨询。但对于无非典型细胞的滤泡性病变,恶性率较低,后期重新评估可能是一种替代方法。